These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 34281830)
21. Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. Burchardt T; Burchardt M; Chen MW; Cao Y; de la Taille A; Shabsigh A; Hayek O; Dorai T; Buttyan R J Urol; 1999 Nov; 162(5):1800-5. PubMed ID: 10524938 [TBL] [Abstract][Full Text] [Related]
22. hASH1 nuclear localization persists in neuroendocrine transdifferentiated prostate cancer cells, even upon reintroduction of androgen. Fraser JA; Sutton JE; Tazayoni S; Bruce I; Poole AV Sci Rep; 2019 Dec; 9(1):19076. PubMed ID: 31836808 [TBL] [Abstract][Full Text] [Related]
23. Neuroendocrine differentiation in prostate carcinoma: focusing on its pathophysiologic mechanisms and pathological features. Alberti C G Chir; 2010; 31(11-12):568-74. PubMed ID: 21232206 [TBL] [Abstract][Full Text] [Related]
24. Gelsolin regulates cisplatin sensitivity in human head-and-neck cancer. Wang PW; Abedini MR; Yang LX; Ding AA; Figeys D; Chang JY; Tsang BK; Shieh DB Int J Cancer; 2014 Dec; 135(12):2760-9. PubMed ID: 24771612 [TBL] [Abstract][Full Text] [Related]
25. Gelsolin Inhibits the Inflammatory Process Induced by LPS. Cheng Y; Hu X; Liu C; Chen M; Wang J; Wang M; Gao F; Han J; Zhang C; Sun D; Min R Cell Physiol Biochem; 2017; 41(1):205-212. PubMed ID: 28135711 [TBL] [Abstract][Full Text] [Related]
26. Upregulation of manganese superoxide dismutase (SOD2) is a common pathway for neuroendocrine differentiation in prostate cancer cells. Quirós I; Sáinz RM; Hevia D; García-Suárez O; Astudillo A; Rivas M; Mayo JC Int J Cancer; 2009 Oct; 125(7):1497-504. PubMed ID: 19507253 [TBL] [Abstract][Full Text] [Related]
28. Differential effects of prostate cancer therapeutics on neuroendocrine transdifferentiation. Frigo DE; McDonnell DP Mol Cancer Ther; 2008 Mar; 7(3):659-69. PubMed ID: 18347151 [TBL] [Abstract][Full Text] [Related]
29. A human- and male-specific protocadherin that acts through the wnt signaling pathway to induce neuroendocrine transdifferentiation of prostate cancer cells. Yang X; Chen MW; Terry S; Vacherot F; Chopin DK; Bemis DL; Kitajewski J; Benson MC; Guo Y; Buttyan R Cancer Res; 2005 Jun; 65(12):5263-71. PubMed ID: 15958572 [TBL] [Abstract][Full Text] [Related]
30. Gelsolin, an Actin-Binding Protein: Bioinformatic Analysis and Functional Significance in Urothelial Bladder Carcinoma. Alsofyani AA; Nedjadi T Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958747 [TBL] [Abstract][Full Text] [Related]
31. siRNA induces gelsolin gene transcription activation in human esophageal cancer cell. Huang GW; Liao LD; Li EM; Xu LY Sci Rep; 2015 Jan; 5():7901. PubMed ID: 25600697 [TBL] [Abstract][Full Text] [Related]
32. Long chain acyl CoA synthetase 1 and gelsolin are oppositely regulated in adipogenesis and lipogenesis. Mukherjee R; Yun JW Biochem Biophys Res Commun; 2012 Apr; 420(3):588-93. PubMed ID: 22445754 [TBL] [Abstract][Full Text] [Related]
33. Overexpression of gelsolin reduces the proliferation and invasion of colon carcinoma cells. Li WX; Yang MX; Hong XQ; Dong TG; Yi T; Lin SL; Qin XY; Niu WX Mol Med Rep; 2016 Oct; 14(4):3059-65. PubMed ID: 27573444 [TBL] [Abstract][Full Text] [Related]
34. Regulation of neuroendocrine differentiation by AKT/hnRNPK/AR/β-catenin signaling in prostate cancer cells. Ciarlo M; Benelli R; Barbieri O; Minghelli S; Barboro P; Balbi C; Ferrari N Int J Cancer; 2012 Aug; 131(3):582-90. PubMed ID: 22015967 [TBL] [Abstract][Full Text] [Related]
35. ATF3 suppresses metastasis of bladder cancer by regulating gelsolin-mediated remodeling of the actin cytoskeleton. Yuan X; Yu L; Li J; Xie G; Rong T; Zhang L; Chen J; Meng Q; Irving AT; Wang D; Williams ED; Liu JP; Sadler AJ; Williams BR; Shen L; Xu D Cancer Res; 2013 Jun; 73(12):3625-37. PubMed ID: 23536558 [TBL] [Abstract][Full Text] [Related]
36. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells. Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222 [TBL] [Abstract][Full Text] [Related]
37. Blocking the Feedback Loop between Neuroendocrine Differentiation and Macrophages Improves the Therapeutic Effects of Enzalutamide (MDV3100) on Prostate Cancer. Wang C; Peng G; Huang H; Liu F; Kong DP; Dong KQ; Dai LH; Zhou Z; Wang KJ; Yang J; Cheng YQ; Gao X; Qu M; Wang HR; Zhu F; Tian QQ; Liu D; Cao L; Cui XG; Xu CL; Xu DF; Sun YH Clin Cancer Res; 2018 Feb; 24(3):708-723. PubMed ID: 29191973 [No Abstract] [Full Text] [Related]
38. Release of macrophage migration inhibitory factor by neuroendocrine-differentiated LNCaP cells sustains the proliferation and survival of prostate cancer cells. Tawadros T; Alonso F; Jichlinski P; Clarke N; Calandra T; Haefliger JA; Roger T Endocr Relat Cancer; 2013 Feb; 20(1):137-49. PubMed ID: 23207293 [TBL] [Abstract][Full Text] [Related]